Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Joshua Kazam
Age : 45
Public asset : 3,308,863 USD
Country of residence : Unknown
Linked companies : Allogene Therapeutics, Inc. - Screaming Eagle Acquisition Corp. - Tishman Speyer Innovation Corp. II - Kronos Bio, Inc.

Biography of Joshua Kazam 
Mr. Joshua A. Kazam is an Independent Director at Soaring Eagle Acquisition Corp., an Independent Director at Tishman Speyer Innovation Corp. II, an Independent Director at TS Innovation Acquisitions Corp., a Director & Partner at Vida Ventures LLC, a Partner at Two River Consulting LLC, a Director & Co-Owner at Riverbank Capital Securities, Inc., a Co-Founder & Partner at Two River Group Holdings LLC, a Co-Founder at VV Manager LLC, a Director & Vice President at Two River Group Management LLC, a Member-Executive Board at The Wharton School of the University of Pennsylvania and a Principal at BCIF Pty Ltd. He is on the Board of Directors at Soaring Eagle Acquisition Corp., Tishman Speyer Innovation Corp. II, TS Innovation Acquisitions Corp., Breakthrough Properties LLC, Breakthrough Services LLC, Allogene Therapeutics, Inc., Vida Ventures LLC, Kronos Bio, Inc., ByHeart, Inc., Desert Flower Foundation GmbH, Vision Path, Inc., MedPod, Inc., Veterinary Prime, Inc., Riverbank Capital Securities, Inc., 105 W First Street LLC, Cortiva Therapy, Danube Pharmaceuticals, Inc., Kirax Corp., Tranzutary Holdings LLC, Vetprime, Inc. and Two River Group Management LLC. Mr. Kazam was previously employed as an Independent Director by Flying Eagle Acquisition Corp., an Independent Director by Diamond Eagle Acquisition Corp., an Independent Director by Platinum Eagle Acquisition Corp., an Independent Director by Capricor Therapeutics, Inc., a Director-Investment Management by Orion Biomedical Fund LP, a Managing Director by Paramount BioCapital, Inc., and a Chief Executive Officer & Director by IconOVir Bio, Inc. He also served on the board at Kite Pharma, Inc., Velcera, Inc., Arno Therapeutics, Inc., Nile Therapeutics, Inc. /Old/, Arno Therapeutics, Inc. /Old/, Manhattan Pharmaceuticals, Inc. and Velcera Pharmaceuticals, Inc. /Old/. He received his undergraduate degree from The Wharton School of the University of Pennsylvania.


Current positions of Joshua Kazam 
Holdings of Joshua Kazam 
Joshua Kazam : Personal Network 
Most Read News 
05/11CATHIE WOOD : Tumble in Coinbase pushes Wood's ARK fund closer to pandemic low
RE
05/12MASAYOSHI SON : SoftBank Vision Fund posts $26 billion loss; Son pledges defence
RE
05/14ELON MUSK : Elon Musk says Twitter legal team told him he violated an NDA
RE
05/11ELON MUSK : Musk's delay in disclosing Twitter stake triggers SEC probe - WSJ
RE
05/05LARRY ELLISON : Musk to lead Twitter temporarily after $44 billion takeover - source
RE
05/10ELON MUSK : Elon Musk says Tesla open to buying a mining company
RE
05/04WARREN BUFFETT : Berkshire shareholders overwhelmingly vote to keep Buffett chairman
RE
05/05JACK DORSEY : Dorsey-led Block beats operating profit estimates, shares surge 10%
RE
05/17JPMorgan shareholders vote disapproval of CEO Dimon's special payout
RE
05/06MARTIN SORRELL : Sorrell's S4 sees good 2022 after publishing delayed results
RE
More news


© 2022 People and Ownership :   
Joshua Kazam : Connections 


Latest news about Joshua Kazam 
01/10Screaming Eagle Acquisition Corp. Announces Executive Appointments
CI
2021Soaring Eagle Acquisition Corp. Announces Board and Committee Appointments
CI
2021Tishman Speyer Innovation Corp. II Announces Board and Committee Changes
CI
2020TS Innovation Acquisitions Corp. Announces Board Appointments
CI
2020Flying Eagle Acquisition Corp. Announces Board Changes; Adopts Second Amended and Restated Certificate of Incorporation
CI
2019Diamond Eagle Acquisition Corp. Announces Executive Changes
CI
2018Allogene Therapeutics, Inc. Announces Board of Directors
CI
More news